BioCardia Stock (NASDAQ: BCDA) stock price, news, charts, stock research, profile.
Open | $0.375 |
Close | $0.380 |
Volume / Avg. | 74.865K / 354.642K |
Day Range | 0.375 - 0.385 |
52 Wk Range | 0.320 - 2.920 |
Market Cap | $10.075M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 2.32% |
Days to Cover | 2.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioCardia (NASDAQ: BCDA) through any online brokerage.
Other companies in BioCardia’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for BioCardia (NASDAQ: BCDA) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a price target for 4.00 expecting BCDA to rise to within 12 months (a possible 966.67% upside). 7 analyst firms have reported ratings in the last year.
The stock price for BioCardia (NASDAQ: BCDA) is $0.375 last updated May 3, 2024 at 7:08 PM EDT.
There are no upcoming dividends for BioCardia.
BioCardia’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for BioCardia.
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.